for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Avrobio Announces New Patients Dosed In Gaucher Disease And Cystinosis Clinical Trials

July 6 (Reuters) - AVROBIO Inc:

* AVROBIO ANNOUNCES NEW PATIENTS DOSED IN GAUCHER DISEASE AND CYSTINOSIS CLINICAL TRIALS

* AVROBIO INC - FIRST PATIENT DOSED IN AVROBIO’S GLOBAL PHASE 1/2 CLINICAL TRIAL OF AVR-RD-02 FOR GAUCHER DISEASE TYPE 1

* AVROBIO INC - SECOND PATIENT DOSED IN INVESTIGATOR-SPONSORED PHASE 1/2 CLINICAL TRIAL OF AVR-RD-04 FOR CYSTINOSIS Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up